EirGenix Statistics
Total Valuation
EirGenix has a market cap or net worth of TWD 15.83 billion. The enterprise value is 14.83 billion.
Important Dates
The next estimated earnings date is Thursday, November 19, 2026.
| Earnings Date | Nov 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EirGenix has 298.65 million shares outstanding. The number of shares has decreased by -1.06% in one year.
| Current Share Class | 298.65M |
| Shares Outstanding | 298.65M |
| Shares Change (YoY) | -1.06% |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | 1.55% |
| Owned by Institutions (%) | 7.90% |
| Float | 188.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 44.92 |
| PS Ratio | 10.72 |
| PB Ratio | 2.04 |
| P/TBV Ratio | 2.26 |
| P/FCF Ratio | 632.23 |
| P/OCF Ratio | 29.72 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 592.22 |
Financial Position
The company has a current ratio of 3.21, with a Debt / Equity ratio of 0.25.
| Current Ratio | 3.21 |
| Quick Ratio | 2.64 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | 77.94 |
| Interest Coverage | -86.92 |
Financial Efficiency
Return on equity (ROE) is -6.20% and return on invested capital (ROIC) is -11.17%.
| Return on Equity (ROE) | -6.20% |
| Return on Assets (ROA) | -4.33% |
| Return on Invested Capital (ROIC) | -11.17% |
| Return on Capital Employed (ROCE) | -7.54% |
| Weighted Average Cost of Capital (WACC) | 5.60% |
| Revenue Per Employee | 1.48M |
| Profits Per Employee | -502,493 |
| Employee Count | 1,000 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 1.51 |
Taxes
| Income Tax | -3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.04% in the last 52 weeks. The beta is 0.36, so EirGenix's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -35.04% |
| 50-Day Moving Average | 50.01 |
| 200-Day Moving Average | 50.91 |
| Relative Strength Index (RSI) | 58.96 |
| Average Volume (20 Days) | 823,752 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EirGenix had revenue of TWD 1.48 billion and -502.49 million in losses. Loss per share was -1.67.
| Revenue | 1.48B |
| Gross Profit | 544.44M |
| Operating Income | -748.35M |
| Pretax Income | -502.50M |
| Net Income | -502.49M |
| EBITDA | -518.24M |
| EBIT | -748.35M |
| Loss Per Share | -1.67 |
Full Income Statement Balance Sheet
The company has 2.95 billion in cash and 1.95 billion in debt, with a net cash position of 1.00 billion or 3.35 per share.
| Cash & Cash Equivalents | 2.95B |
| Total Debt | 1.95B |
| Net Cash | 1.00B |
| Net Cash Per Share | 3.35 |
| Equity (Book Value) | 7.77B |
| Book Value Per Share | 25.53 |
| Working Capital | 2.84B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 532.63 million and capital expenditures -507.60 million, giving a free cash flow of 25.04 million.
| Operating Cash Flow | 532.63M |
| Capital Expenditures | -507.60M |
| Depreciation & Amortization | 230.12M |
| Net Borrowing | 661.85M |
| Free Cash Flow | 25.04M |
| FCF Per Share | 0.08 |
Full Cash Flow Statement Margins
Gross margin is 36.86%, with operating and profit margins of -50.66% and -34.02%.
| Gross Margin | 36.86% |
| Operating Margin | -50.66% |
| Pretax Margin | -34.02% |
| Profit Margin | -34.02% |
| EBITDA Margin | -35.08% |
| EBIT Margin | -50.66% |
| FCF Margin | 1.69% |
Dividends & Yields
EirGenix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.06% |
| Shareholder Yield | 1.06% |
| Earnings Yield | -3.16% |
| FCF Yield | 0.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |